HEADER UNKNOWN FUNCTION 20-JUN-08 2VWA TITLE CRYSTAL STRUCTURE OF A SPOROZOITE PROTEIN ESSENTIAL FOR TITLE 2 LIVER STAGE DEVELOPMENT OF MALARIA PARASITE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE UNCHARACTERIZED PROTEIN PF13_0012; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 FRAGMENT: RESIDUES 129-228; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: UPREGULATED IN INFECTIVE SPOROZOITES COMPND 7 PROTEIN 3 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_COMMON: MALARIA PARASITE; SOURCE 4 ORGANISM_TAXID: 36329; SOURCE 5 STRAIN: 3D7; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: B834 (DE3); SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX4T1 KEYWDS UNKNOWN FUNCTION EXPDTA X-RAY DIFFRACTION AUTHOR A.SHARMA,A.SHARMA,M.YOGAVEL,J.GILL,R.R.AKHOURI REVDAT 4 24-FEB-09 2VWA 1 VERSN REVDAT 3 02-SEP-08 2VWA 1 JRNL REVDAT 2 15-JUL-08 2VWA 1 AUTHOR REVDAT 1 08-JUL-08 2VWA 0 JRNL AUTH A.SHARMA,M.YOGAVEL,R.R.AKHOURI,J.GILL,A.SHARMA JRNL TITL CRYSTAL STRUCTURE OF SOLUBLE DOMAIN OF MALARIA JRNL TITL 2 SPOROZOITE PROTEIN UIS3 IN COMPLEX WITH LIPID. JRNL REF J.BIOL.CHEM. V. 283 24077 2008 JRNL REFN ISSN 0021-9258 JRNL PMID 18577521 JRNL DOI 10.1074/JBC.M801946200 REMARK 2 REMARK 2 RESOLUTION. 2.5 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 30400 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.223 REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1619 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.57 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2203 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2520 REMARK 3 BIN FREE R VALUE SET COUNT : 113 REMARK 3 BIN FREE R VALUE : 0.3180 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4860 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 444 REMARK 3 SOLVENT ATOMS : 135 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.96 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.67000 REMARK 3 B22 (A**2) : 1.34000 REMARK 3 B33 (A**2) : -0.67000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.13000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.446 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.292 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.180 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.780 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.914 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.870 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5376 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7146 ; 1.476 ; 1.982 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 588 ; 4.906 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 306 ;44.725 ;26.275 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1014 ;19.009 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;15.612 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 726 ; 0.106 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3936 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2280 ; 0.224 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3612 ; 0.304 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 208 ; 0.166 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 92 ; 0.255 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 9 ; 0.262 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3074 ; 1.157 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4812 ; 1.738 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2543 ; 3.037 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2334 ; 4.435 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 2VWA COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-JUN-08. REMARK 100 THE PDBE ID CODE IS EBI-36626. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9788 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL2000 REMARK 200 DATA SCALING SOFTWARE : HKL2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32131 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.50 REMARK 200 RESOLUTION RANGE LOW (A) : 25.00 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 9.9 REMARK 200 R MERGE (I) : 0.09 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 29.65 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 9.0 REMARK 200 R MERGE FOR SHELL (I) : 0.29 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 8.10 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SHELXD, PHENIX REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLIZED FROM REMARK 280 0.1 M MES PH 6.5, 12% PEG 20,000 AND 0.01 M DTT REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 19.13700 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 129 REMARK 465 ILE B 129 REMARK 465 ILE C 129 REMARK 465 ILE D 129 REMARK 465 ILE E 129 REMARK 465 ILE F 129 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 229 CA C O CB CG OD1 ND2 REMARK 470 ASN B 229 CA C O CB CG OD1 ND2 REMARK 470 ASN C 229 CA C O CB CG OD1 ND2 REMARK 470 ASN D 229 CA C O CB CG OD1 ND2 REMARK 470 ASN E 229 CA C O CB CG OD1 ND2 REMARK 470 ASN F 229 CA C O CB CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 VAL A 179 CB - CA - C ANGL. DEV. = -11.4 DEGREES REMARK 500 VAL F 179 CB - CA - C ANGL. DEV. = -13.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN B 197 56.64 38.01 REMARK 500 GLU E 227 25.44 -63.92 REMARK 500 ASN F 143 123.53 -171.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PTY D1230 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PTY F1230 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PTY C1230 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PTY A1230 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PTY E1230 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PTY B1230 DBREF 2VWA A 129 229 UNP Q8IEU1 Q8IEU1_PLAF7 129 229 DBREF 2VWA B 129 229 UNP Q8IEU1 Q8IEU1_PLAF7 129 229 DBREF 2VWA D 129 229 UNP Q8IEU1 Q8IEU1_PLAF7 129 229 DBREF 2VWA C 129 229 UNP Q8IEU1 Q8IEU1_PLAF7 129 229 DBREF 2VWA D 129 229 UNP Q8IEU1 Q8IEU1_PLAF7 129 229 DBREF 2VWA E 129 229 UNP Q8IEU1 Q8IEU1_PLAF7 129 229 DBREF 2VWA F 129 229 UNP Q8IEU1 Q8IEU1_PLAF7 129 229 SEQRES 1 A 101 ILE ASN LYS ILE ASN LEU ASN LYS PRO ILE ILE GLU ASN SEQRES 2 A 101 LYS ASN ASN VAL ASP VAL SER ILE LYS ARG TYR ASN ASN SEQRES 3 A 101 PHE VAL ASP ILE ALA ARG LEU SER ILE GLN LYS HIS PHE SEQRES 4 A 101 GLU HIS LEU SER ASN ASP GLN LYS ASP SER HIS VAL ASN SEQRES 5 A 101 ASN MSE GLU TYR MSE GLN LYS PHE VAL GLN GLY LEU GLN SEQRES 6 A 101 GLU ASN ARG ASN ILE SER LEU SER LYS TYR GLN GLU ASN SEQRES 7 A 101 LYS ALA VAL MSE ASP LEU LYS TYR HIS LEU GLN LYS VAL SEQRES 8 A 101 TYR ALA ASN TYR LEU SER GLN GLU GLU ASN SEQRES 1 B 101 ILE ASN LYS ILE ASN LEU ASN LYS PRO ILE ILE GLU ASN SEQRES 2 B 101 LYS ASN ASN VAL ASP VAL SER ILE LYS ARG TYR ASN ASN SEQRES 3 B 101 PHE VAL ASP ILE ALA ARG LEU SER ILE GLN LYS HIS PHE SEQRES 4 B 101 GLU HIS LEU SER ASN ASP GLN LYS ASP SER HIS VAL ASN SEQRES 5 B 101 ASN MSE GLU TYR MSE GLN LYS PHE VAL GLN GLY LEU GLN SEQRES 6 B 101 GLU ASN ARG ASN ILE SER LEU SER LYS TYR GLN GLU ASN SEQRES 7 B 101 LYS ALA VAL MSE ASP LEU LYS TYR HIS LEU GLN LYS VAL SEQRES 8 B 101 TYR ALA ASN TYR LEU SER GLN GLU GLU ASN SEQRES 1 C 101 ILE ASN LYS ILE ASN LEU ASN LYS PRO ILE ILE GLU ASN SEQRES 2 C 101 LYS ASN ASN VAL ASP VAL SER ILE LYS ARG TYR ASN ASN SEQRES 3 C 101 PHE VAL ASP ILE ALA ARG LEU SER ILE GLN LYS HIS PHE SEQRES 4 C 101 GLU HIS LEU SER ASN ASP GLN LYS ASP SER HIS VAL ASN SEQRES 5 C 101 ASN MSE GLU TYR MSE GLN LYS PHE VAL GLN GLY LEU GLN SEQRES 6 C 101 GLU ASN ARG ASN ILE SER LEU SER LYS TYR GLN GLU ASN SEQRES 7 C 101 LYS ALA VAL MSE ASP LEU LYS TYR HIS LEU GLN LYS VAL SEQRES 8 C 101 TYR ALA ASN TYR LEU SER GLN GLU GLU ASN SEQRES 1 D 101 ILE ASN LYS ILE ASN LEU ASN LYS PRO ILE ILE GLU ASN SEQRES 2 D 101 LYS ASN ASN VAL ASP VAL SER ILE LYS ARG TYR ASN ASN SEQRES 3 D 101 PHE VAL ASP ILE ALA ARG LEU SER ILE GLN LYS HIS PHE SEQRES 4 D 101 GLU HIS LEU SER ASN ASP GLN LYS ASP SER HIS VAL ASN SEQRES 5 D 101 ASN MSE GLU TYR MSE GLN LYS PHE VAL GLN GLY LEU GLN SEQRES 6 D 101 GLU ASN ARG ASN ILE SER LEU SER LYS TYR GLN GLU ASN SEQRES 7 D 101 LYS ALA VAL MSE ASP LEU LYS TYR HIS LEU GLN LYS VAL SEQRES 8 D 101 TYR ALA ASN TYR LEU SER GLN GLU GLU ASN SEQRES 1 E 101 ILE ASN LYS ILE ASN LEU ASN LYS PRO ILE ILE GLU ASN SEQRES 2 E 101 LYS ASN ASN VAL ASP VAL SER ILE LYS ARG TYR ASN ASN SEQRES 3 E 101 PHE VAL ASP ILE ALA ARG LEU SER ILE GLN LYS HIS PHE SEQRES 4 E 101 GLU HIS LEU SER ASN ASP GLN LYS ASP SER HIS VAL ASN SEQRES 5 E 101 ASN MSE GLU TYR MSE GLN LYS PHE VAL GLN GLY LEU GLN SEQRES 6 E 101 GLU ASN ARG ASN ILE SER LEU SER LYS TYR GLN GLU ASN SEQRES 7 E 101 LYS ALA VAL MSE ASP LEU LYS TYR HIS LEU GLN LYS VAL SEQRES 8 E 101 TYR ALA ASN TYR LEU SER GLN GLU GLU ASN SEQRES 1 F 101 ILE ASN LYS ILE ASN LEU ASN LYS PRO ILE ILE GLU ASN SEQRES 2 F 101 LYS ASN ASN VAL ASP VAL SER ILE LYS ARG TYR ASN ASN SEQRES 3 F 101 PHE VAL ASP ILE ALA ARG LEU SER ILE GLN LYS HIS PHE SEQRES 4 F 101 GLU HIS LEU SER ASN ASP GLN LYS ASP SER HIS VAL ASN SEQRES 5 F 101 ASN MSE GLU TYR MSE GLN LYS PHE VAL GLN GLY LEU GLN SEQRES 6 F 101 GLU ASN ARG ASN ILE SER LEU SER LYS TYR GLN GLU ASN SEQRES 7 F 101 LYS ALA VAL MSE ASP LEU LYS TYR HIS LEU GLN LYS VAL SEQRES 8 F 101 TYR ALA ASN TYR LEU SER GLN GLU GLU ASN MODRES 2VWA MSE A 182 MET SELENOMETHIONINE MODRES 2VWA MSE A 185 MET SELENOMETHIONINE MODRES 2VWA MSE A 210 MET SELENOMETHIONINE MODRES 2VWA MSE B 182 MET SELENOMETHIONINE MODRES 2VWA MSE B 185 MET SELENOMETHIONINE MODRES 2VWA MSE B 210 MET SELENOMETHIONINE MODRES 2VWA MSE C 182 MET SELENOMETHIONINE MODRES 2VWA MSE C 185 MET SELENOMETHIONINE MODRES 2VWA MSE C 210 MET SELENOMETHIONINE MODRES 2VWA MSE D 182 MET SELENOMETHIONINE MODRES 2VWA MSE D 185 MET SELENOMETHIONINE MODRES 2VWA MSE D 210 MET SELENOMETHIONINE MODRES 2VWA MSE E 182 MET SELENOMETHIONINE MODRES 2VWA MSE E 185 MET SELENOMETHIONINE MODRES 2VWA MSE E 210 MET SELENOMETHIONINE MODRES 2VWA MSE F 182 MET SELENOMETHIONINE MODRES 2VWA MSE F 185 MET SELENOMETHIONINE MODRES 2VWA MSE F 210 MET SELENOMETHIONINE HET MSE A 182 8 HET MSE A 185 8 HET MSE A 210 8 HET MSE B 182 8 HET MSE B 185 8 HET MSE B 210 8 HET MSE C 182 8 HET MSE C 185 8 HET MSE C 210 8 HET MSE D 182 8 HET MSE D 185 8 HET MSE D 210 8 HET MSE E 182 8 HET MSE E 185 8 HET MSE E 210 8 HET MSE F 182 8 HET MSE F 185 8 HET MSE F 210 8 HET PTY D1230 50 HET PTY F1230 50 HET PTY C1230 50 HET PTY A1230 50 HET PTY E1230 50 HET PTY B1230 50 HETNAM PTY PHOSPHATIDYLETHANOLAMINE HETNAM MSE SELENOMETHIONINE FORMUL 7 PTY 6(C40 H80 N O8 P) FORMUL 8 MSE 18(C5 H11 N O2 SE) FORMUL 9 HOH *135(H2 O1) HELIX 1 1 SER A 148 LEU A 170 1 23 HELIX 2 2 SER A 171 VAL A 179 1 9 HELIX 3 3 ASN A 181 ARG A 196 1 16 HELIX 4 4 SER A 201 GLU A 228 1 28 HELIX 5 5 SER B 148 LEU B 170 1 23 HELIX 6 6 SER B 171 VAL B 179 1 9 HELIX 7 7 ASN B 181 ARG B 196 1 16 HELIX 8 8 SER B 201 GLU B 228 1 28 HELIX 9 9 SER C 148 LEU C 170 1 23 HELIX 10 10 SER C 171 VAL C 179 1 9 HELIX 11 11 ASN C 181 ASN C 197 1 17 HELIX 12 12 SER C 201 GLU C 228 1 28 HELIX 13 13 SER D 148 LEU D 170 1 23 HELIX 14 14 SER D 171 VAL D 179 1 9 HELIX 15 15 ASN D 181 ARG D 196 1 16 HELIX 16 16 SER D 201 GLU D 228 1 28 HELIX 17 17 SER E 148 GLU E 168 1 21 HELIX 18 18 SER E 171 VAL E 179 1 9 HELIX 19 19 ASN E 181 ARG E 196 1 16 HELIX 20 20 SER E 201 GLU E 227 1 27 HELIX 21 21 SER F 148 LEU F 170 1 23 HELIX 22 22 SER F 171 VAL F 179 1 9 HELIX 23 23 ASN F 181 ARG F 196 1 16 HELIX 24 24 SER F 201 GLU F 228 1 28 LINK C ASN A 181 N MSE A 182 1555 1555 1.33 LINK C MSE A 182 N GLU A 183 1555 1555 1.33 LINK C TYR A 184 N MSE A 185 1555 1555 1.32 LINK C MSE A 185 N GLN A 186 1555 1555 1.33 LINK C VAL A 209 N MSE A 210 1555 1555 1.33 LINK C MSE A 210 N ASP A 211 1555 1555 1.33 LINK C ASN B 181 N MSE B 182 1555 1555 1.33 LINK C MSE B 182 N GLU B 183 1555 1555 1.33 LINK C TYR B 184 N MSE B 185 1555 1555 1.32 LINK C MSE B 185 N GLN B 186 1555 1555 1.33 LINK C VAL B 209 N MSE B 210 1555 1555 1.33 LINK C MSE B 210 N ASP B 211 1555 1555 1.33 LINK C ASN C 181 N MSE C 182 1555 1555 1.33 LINK C MSE C 182 N GLU C 183 1555 1555 1.34 LINK C TYR C 184 N MSE C 185 1555 1555 1.32 LINK C MSE C 185 N GLN C 186 1555 1555 1.33 LINK C VAL C 209 N MSE C 210 1555 1555 1.33 LINK C MSE C 210 N ASP C 211 1555 1555 1.32 LINK C ASN D 181 N MSE D 182 1555 1555 1.33 LINK C MSE D 182 N GLU D 183 1555 1555 1.33 LINK C TYR D 184 N MSE D 185 1555 1555 1.32 LINK C MSE D 185 N GLN D 186 1555 1555 1.34 LINK C VAL D 209 N MSE D 210 1555 1555 1.33 LINK C MSE D 210 N ASP D 211 1555 1555 1.33 LINK C ASN E 181 N MSE E 182 1555 1555 1.34 LINK C MSE E 182 N GLU E 183 1555 1555 1.33 LINK C TYR E 184 N MSE E 185 1555 1555 1.32 LINK C MSE E 185 N GLN E 186 1555 1555 1.33 LINK C VAL E 209 N MSE E 210 1555 1555 1.32 LINK C MSE E 210 N ASP E 211 1555 1555 1.32 LINK C ASN F 181 N MSE F 182 1555 1555 1.32 LINK C MSE F 182 N GLU F 183 1555 1555 1.33 LINK C TYR F 184 N MSE F 185 1555 1555 1.33 LINK C MSE F 185 N GLN F 186 1555 1555 1.33 LINK C VAL F 209 N MSE F 210 1555 1555 1.32 LINK C MSE F 210 N ASP F 211 1555 1555 1.32 SITE 1 AC1 9 GLN D 164 GLU D 168 LYS D 207 ASP D 211 SITE 2 AC1 9 TYR D 214 LYS D 218 VAL D 219 ASN D 222 SITE 3 AC1 9 GLN D 226 SITE 1 AC2 7 GLN F 164 GLU F 168 LYS F 207 ASP F 211 SITE 2 AC2 7 LYS F 218 VAL F 219 ASN F 222 SITE 1 AC3 9 GLN C 164 GLU C 168 LYS C 207 MSE C 210 SITE 2 AC3 9 ASP C 211 LYS C 218 ASN C 222 ASN D 130 SITE 3 AC3 9 LYS D 165 SITE 1 AC4 8 GLN A 164 GLU A 168 LYS A 207 ASP A 211 SITE 2 AC4 8 LYS A 218 ASN B 130 LYS B 165 MSE B 210 SITE 1 AC5 6 GLN E 164 GLU E 168 ASP E 211 LYS E 218 SITE 2 AC5 6 VAL E 219 ASN E 222 SITE 1 AC6 8 LYS A 165 ARG B 160 GLN B 164 GLU B 168 SITE 2 AC6 8 ASP B 211 LYS B 218 ASN B 222 HOH B2028 CRYST1 82.544 38.274 145.696 90.00 90.25 90.00 P 1 21 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012115 0.000000 0.000053 0.00000 SCALE2 0.000000 0.026127 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006864 0.00000